Cargando…

Education level as a predictor of survival in patients with multiple myeloma

BACKGROUND: Disparities in multiple myeloma (MM) prognosis based on sociodemographic factors may exist. We investigated whether education level at diagnosis influenced Chinese MM patient outcomes. METHODS: We performed a multicenter retrospective analysis of data from 773 MM patients across 9 center...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Limei, Wang, Xiuju, Pan, Xueyi, Wang, Xiaotao, Wang, Qing, Wu, Bingyi, Cai, Jiahui, Zhao, Ying, Chen, Lijuan, Li, Wuping, Li, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414648/ https://www.ncbi.nlm.nih.gov/pubmed/32770980 http://dx.doi.org/10.1186/s12885-020-07178-5

Ejemplares similares

Time-dependent endpoints as predictors of overall survival in multiple myeloma
por: Félix, Jorge, et al.
Publicado: (2013)

Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma
por: Li, Xiaozhe, et al.
Publicado: (2023)

Clinical characteristics and survival of patients with IgD multiple myeloma
por: Li, Yi, et al.
Publicado: (2021)

A prognostic model for patients with primary extramedullary multiple myeloma
por: Zhang, Limei, et al.
Publicado: (2022)

Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients
por: Wang, Jie, et al.
Publicado: (2021)

Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients
por: Ren, Yuyue, et al.
Publicado: (2023)

Genetic Predictors of Mortality in Patients with Multiple Myeloma
por: Hassan, Hamza, et al.
Publicado: (2021)

Impact of connexin 43 coupling on survival and migration of multiple myeloma cells
por: Zhang, Yangmin, et al.
Publicado: (2017)

Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance
por: Pan, Jing, et al.
Publicado: (2017)

Long-term survival in multiple myeloma
por: João, Cristina, et al.
Publicado: (2014)

Bone marrow IRF4 level in multiple myeloma: an indicator of peripheral blood Th17 and disease
por: Bai, Hua, et al.
Publicado: (2017)

Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib
por: Mikulski, Damian, et al.
Publicado: (2021)

Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China
por: Sun, Hailu, et al.
Publicado: (2023)

Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
por: Zhang, Limei, et al.
Publicado: (2022)

Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Limei, et al.
Publicado: (2023)

Trends in overall survival and costs of multiple myeloma, 2000–2014
por: Fonseca, R, et al.
Publicado: (2017)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2020)

Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes
por: Uckun, Fatih M., et al.
Publicado: (2023)

Socioeconomic Factors and Survival of Multiple Myeloma Patients
por: Chamoun, Kamal, et al.
Publicado: (2021)

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma
por: Wang, Liang, et al.
Publicado: (2015)

Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor
por: Wang, Ying, et al.
Publicado: (2022)

CD138(-) multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient
por: Wu, Dong, et al.
Publicado: (2020)

TRPV2-induced Ca(2+)-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma
por: Bai, Hua, et al.
Publicado: (2018)

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project
por: Usmani, Saad Z., et al.
Publicado: (2018)

HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma
por: Yang, Jie, et al.
Publicado: (2020)

Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma
por: Atrash, Shebli, et al.
Publicado: (2018)

Racial differences as predictors of outcomes in young patients with multiple myeloma
por: Bao, Alicia, et al.
Publicado: (2022)

BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions
por: Zhang, Danfeng, et al.
Publicado: (2021)

Association of response endpoints with survival outcomes in multiple myeloma
por: Lonial, S, et al.
Publicado: (2014)

Treatment evolution and improved survival in multiple myeloma in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
por: Giannopoulos, K, et al.
Publicado: (2012)

Survival rate of multiple myeloma patients in Indonesia: A retrospective study in multiple myeloma at a single institution
por: Andriandi, et al.
Publicado: (2019)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Multiple myeloma with dural mater involvement
por: Liu, Su, et al.
Publicado: (2019)

Circulating resistin levels and risk of multiple myeloma in three prospective cohorts
por: Santo, Loredana, et al.
Publicado: (2017)

Fear of cancer recurrence in patients with multiple myeloma: Prevalence and predictors based on a family model analysis
por: Hu, Xiaochun, et al.
Publicado: (2020)

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma
por: Li, Yang, et al.
Publicado: (2021)

Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases
por: Acquah, Michael E, et al.
Publicado: (2019)

Emerging agents and regimens for multiple myeloma
por: Yang, Yang, et al.
Publicado: (2020)

Curability of Multiple Myeloma
por: Alexanian, Raymond, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b6o3cvd26b5liepg6s1tuhgo8b